- Home
- HIHO vs BCLI Comparison
HIHO vs BCLI Comparison
Compare HIHO & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- BCLI
- Stock Information
- Founded
- HIHO 1990
- BCLI 2000
- Country
- HIHO Hong Kong
- BCLI United States
- Employees
- HIHO N/A
- BCLI N/A
- Industry
- HIHO Industrial Machinery/Components
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HIHO Industrials
- BCLI Health Care
- Exchange
- HIHO Nasdaq
- BCLI Nasdaq
- Market Cap
- HIHO 8.3M
- BCLI 9.8M
- IPO Year
- HIHO 1996
- BCLI N/A
- Fundamental
- Price
- HIHO $1.63
- BCLI $1.16
- Analyst Decision
- HIHO
- BCLI Strong Buy
- Analyst Count
- HIHO 0
- BCLI 1
- Target Price
- HIHO N/A
- BCLI $30.00
- AVG Volume (30 Days)
- HIHO 11.2K
- BCLI 409.2K
- Earning Date
- HIHO 07-31-2025
- BCLI 08-13-2025
- Dividend Yield
- HIHO 7.36%
- BCLI N/A
- EPS Growth
- HIHO N/A
- BCLI N/A
- EPS
- HIHO 0.02
- BCLI N/A
- Revenue
- HIHO $7,412,000.00
- BCLI N/A
- Revenue This Year
- HIHO N/A
- BCLI N/A
- Revenue Next Year
- HIHO N/A
- BCLI N/A
- P/E Ratio
- HIHO $82.00
- BCLI N/A
- Revenue Growth
- HIHO 17.26
- BCLI N/A
- 52 Week Low
- HIHO $1.40
- BCLI $0.72
- 52 Week High
- HIHO $2.88
- BCLI $6.45
- Technical
- Relative Strength Index (RSI)
- HIHO 27.65
- BCLI 49.98
- Support Level
- HIHO $1.69
- BCLI $1.02
- Resistance Level
- HIHO $1.75
- BCLI $1.32
- Average True Range (ATR)
- HIHO 0.04
- BCLI 0.09
- MACD
- HIHO -0.02
- BCLI -0.00
- Stochastic Oscillator
- HIHO 0.00
- BCLI 46.67
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.